Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, coronavirus, 2019-nCoV, Remdesivir, Chloroquine phosphate, plasma, lopinavir/ ritonavir, abidol, 【초록키워드】 Vaccine, antibody, Novel coronavirus, Patient, Therapeutic strategies, plasma, deaths, COVID-19 patient, stem cell, therapeutic intervention, over, effective, resulting, reported, Potential, 【제목키워드】 Strategy, COVID-19 patient,
【저자키워드】 COVID-19, SARS-CoV-2, coronavirus, 2019-nCoV, Remdesivir, Chloroquine phosphate, plasma, lopinavir/ ritonavir, abidol, 【초록키워드】 Vaccine, antibody, Novel coronavirus, Patient, Therapeutic strategies, plasma, deaths, COVID-19 patient, stem cell, therapeutic intervention, over, effective, resulting, reported, Potential, 【제목키워드】 Strategy, COVID-19 patient,